A critical discovery in cancer study is occurring with the use of VHH fragments to reactivate mutated p53. This vital malignant protector protein is frequently disabled in many forms of cancer, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research